Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

about

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

Item

http://www.wikidata.org/entity/Q54220808

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@en

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@nl

type

Item

label

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@en

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@nl

prefLabel

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@en

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

@nl

P1476

Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer

@en

P2093

Buor-Chang Wu

http://www.w3.org/2001/XMLSchema#string

Chun-Yi Chuang

http://www.w3.org/2001/XMLSchema#string

Dar-Ren Chen

http://www.w3.org/2001/XMLSchema#string

Hsiu-Ting Tsai

http://www.w3.org/2001/XMLSchema#string

Shun-Fa Yang

http://www.w3.org/2001/XMLSchema#string

Yu-Hsien Peng

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance

Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.

Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.

The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes

Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.

In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.

Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.

P304

287-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCLA.21682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24578158

http://www.w3.org/2001/XMLSchema#string

P932

6807465

http://www.w3.org/2001/XMLSchema#string